113 related articles for article (PubMed ID: 15900897)
1. Clinical and clinicopathological changes in 6 healthy ponies following intramuscular administration of multiple doses of imidocarb dipropionate.
Meyer C; Guthrie AJ; Stevens KB
J S Afr Vet Assoc; 2005 Mar; 76(1):26-32. PubMed ID: 15900897
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration.
Belloli C; Crescenzo G; Lai O; Carofiglio V; Marang O; Ormas P
Equine Vet J; 2002 Sep; 34(6):625-9. PubMed ID: 12358005
[TBL] [Abstract][Full Text] [Related]
3. Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids.
Kuttler KL; Zaugg JL; Gipson CA
Am J Vet Res; 1987 Nov; 48(11):1613-6. PubMed ID: 3434908
[TBL] [Abstract][Full Text] [Related]
4. Could treatment of pregnant mares prevent abortions due to equine piroplasmosis?
Lewis BD; Penzhorn BL; Volkmann DH
J S Afr Vet Assoc; 1999 Jun; 70(2):90-1. PubMed ID: 10855828
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium methyl arsinate and imidocarb dipropionate antiprotozoal drugs on the pharmacokinetic of gentamicin in equines.
Soliman GA
Dtsch Tierarztl Wochenschr; 1998 Jul; 105(7):274-6. PubMed ID: 9697352
[TBL] [Abstract][Full Text] [Related]
6. Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization.
Butler CM; Nijhof AM; van der Kolk JH; de Haseth OB; Taoufik A; Jongejan F; Houwers DJ
Vet Parasitol; 2008 Feb; 151(2-4):320-2. PubMed ID: 18160222
[TBL] [Abstract][Full Text] [Related]
7. Alterations of blood parameters after intramuscular administration of imidocarb in healthy lambs.
Ekici OD; Isik N
Drug Chem Toxicol; 2012 Apr; 35(2):162-6. PubMed ID: 21834689
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic activity of imidocarb against experimental infection with Babesia canis.
Vercammen F; De Deken R; Maes L
Vet Parasitol; 1996 Jun; 63(3-4):195-8. PubMed ID: 8966987
[TBL] [Abstract][Full Text] [Related]
9. Effects of inflammation-associated acute-phase response on hepatic and renal indices in the horse.
Mills PC; Auer DE; Kramer H; Barry D; Ng JC
Aust Vet J; 1998 Mar; 76(3):187-94. PubMed ID: 9578755
[TBL] [Abstract][Full Text] [Related]
10. Equine babesiosis associated with strenuous exercise: clinical and pathological studies in Jordan.
Hailat NQ; Lafi SQ; al-Darraji AM; al-Ani FK
Vet Parasitol; 1997 Apr; 69(1-2):1-8. PubMed ID: 9187024
[TBL] [Abstract][Full Text] [Related]
11. Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
Hines SA; Ramsay JD; Kappmeyer LS; Lau AO; Ojo KK; Van Voorhis WC; Knowles DP; Mealey RH
Parasit Vectors; 2015 Jan; 8():33. PubMed ID: 25600252
[TBL] [Abstract][Full Text] [Related]
12. Imidocarb: a chemoprophylactic experiment with Babesia canis.
Uilenberg G; Verdiesen PA; Zwart D
Vet Q; 1981 Jul; 3(3):118-23. PubMed ID: 7268745
[TBL] [Abstract][Full Text] [Related]
13. The effect of neomycin on the kidney function of the horse.
Fuentes VO; Gonzalez H; Sanchez V; Fuentes P; Rosiles R
Zentralbl Veterinarmed A; 1997 Jun; 44(4):201-5. PubMed ID: 9270342
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses.
Abutarbush SM; Alfaqeeh SM; Mustafa G; Qura'n L; Al-Majali AM
Am J Vet Res; 2013 Nov; 74(11):1404-8. PubMed ID: 24168305
[TBL] [Abstract][Full Text] [Related]
15. Ovine and caprine babesiosis in Iran: treatment with imidocarb.
Hashemi-Fesharki R
Vet Rec; 1991 Oct; 129(17):383-4. PubMed ID: 1746117
[No Abstract] [Full Text] [Related]
16. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
Kumar S; Gupta AK; Pal Y; Dwivedi SK
J Vet Med Sci; 2003 Nov; 65(11):1171-7. PubMed ID: 14665744
[TBL] [Abstract][Full Text] [Related]
17. Equine piroplasmosis treatment protocols: specific effect on orocaecal transit time as measured by the lactose 13C-ureide breath test.
Kutscha J; Sutton DG; Preston T; Guthrie AJ
Equine Vet J Suppl; 2012 Dec; (43):62-7. PubMed ID: 23447880
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses.
Grause JF; Ueti MW; Nelson JT; Knowles DP; Kappmeyer LS; Bunn TO
Vet J; 2013 Jun; 196(3):541-6. PubMed ID: 23199699
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy against babesiosis.
Vial HJ; Gorenflot A
Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of imidocarb dipropionate in swine.
Su D; Li XB; Wang ZJ; Wang L; Wu WX; Xu JQ
J Vet Pharmacol Ther; 2007 Aug; 30(4):366-70. PubMed ID: 17610411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
